Full Press Release Details
to Host Third Quarter 2025 Investor Conference Call
22, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading
global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter
2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results
for the third quarter 2025 before the opening of markets that same day.
| DATE: | Wednesday, February 5, 2025 |
| TIME: | 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time |
| WEBCAST: | Click Here |
Miguel Martin, Executive
Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer
period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under
About Aurora Cannabis
Aurora is opening the
world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in
Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use
brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf,
CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has
a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the
medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow
us on X and LinkedIn.
Aurora's common shares
trade on the NASDAQ and TSX under the symbol "ACB".
This news release includes
statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking
statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue",
"expect", "project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed" and other similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements
regarding the timing for the release of the Company's fiscal 2025 Q3 financial statements and the conference call to discuss the results.
These forward-looking
statements are only predictions. Forward looking information or statements contained in this news release have been developed based on
assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis
and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements
are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances
could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel,
the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the development of third party government and non-government consumer sales
channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations
of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction
and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue
growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market
conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the
possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other
risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June
20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+
at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of
risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results.
Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are
cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention
or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,
except as expressly required by applicable securities law.
View original content
SOURCE Aurora Cannabis
View original content
to download multimedia: http://www.newswire.ca/en/releases/archive/January2025/22/c6893.html
For further information: For Media:
Michelle Lefler, VP, Communications & PR, media@auroramj.com; For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com
CNW 17:02e 22-JAN-25